Earnings Report Digest

$DELL has released its earnings for Q1 2026. Key stats show revenue at $23.38B, up 5.1% Y/Y, but EPS of $1.55 missed estimates by $0.14. Early indications suggest risks in consumer demand, having declined 19%, while the enterprise sector continues to drive growth.

$COST has released its Q3 2025 earnings, showcasing an EPS of $4.28, beating estimates by $0.04, with revenues of $63.21B, a robust 8.02% increase year-over-year. However, risks include inflation impacts on inventory and ongoing tariffs, which caused a $130 million LIFO charge this quarter, stressing financial health.

$INTU announced its Q3 earnings, revealing impressive revenue growth of 15%, hitting $7.75B, and beat EPS estimates at $1.65. Key risks include slightly declining shares in TurboTax units due to market dynamics.

$ZM has released its Q1 2026 earnings, reporting an EPS of $1.43, beating estimates by $0.12. Revenue reached $1.17B, growing 2.93% year-over-year and surpassing projections. Highlights include a low churn rate of 2.8%, reflecting strong customer retention. However, the Enterprise segment outlook is cautious due to elongated deal cycles amid macroeconomic challenges.

$TGT just released its Q1 2025 earnings. EPS of $1.30 missed expectations by $0.35, with revenue at $23.85B down 2.79% year-over-year, reflecting ongoing challenges in discretionary spending and consumer confidence.

$SNOW has released its Q1 2026 earnings, reporting an EPS of $0.24, which beat expectations by $0.03. Revenue grew to $1.04 billion, up 25.75% Y/Y, surpassing forecasts by $36.39 million. Key metrics include a gross margin of 75.7% and a healthy net revenue retention of 124%. Risks include potential market fluctuations and customer consumption trends.

$MDT is here with their latest earnings release. For Q4 2025, Medtronic reported an EPS of $1.62, exceeding expectations by $0.04, and revenues of $8.93B, reflecting a 3.94% year-over-year growth. Key highlights include an 8% surge in the cardiovascular sector and a strategic move to separate its diabetes business, enhancing focus on high-margin growth areas. However, risks include tariff impacts of $200M–$350M and gross margin headwinds.

$TJX has released its Q1 2026 earnings, showing a quarterly EPS of $0.92, beating expectations by $0.01, with revenue reaching $13.11B, a year-over-year growth of 5.06%. 🚀 Key highlights include a pretax profit margin of 10.3%, down slightly from last year, and a strong comp sales growth of 3%. 📈 However, the future may hold risks with ongoing tariff pressures and fluctuating gross margins. Despite this, TJX remains optimistic about navigating these challenges. For more details, visit valueverge.com/TJX.

$LOW reports Q1 2025 results with EPS of $2.92, slightly beating estimates. However, revenue fell 2.03% YOY to $20.93B, raising concerns about the ongoing pressure in the DIY sector💼.

$DE has released its Q2 earnings, reporting an EPS of $6.64, beating expectations by $1.02, despite a revenue drop of 17.92% year-over-year to $11.17B. Key aspects include a strong profit margin of 18.8% in equipment operations, showcasing operational resilience amid macro uncertainties.